{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:32:40Z","timestamp":1787934760758,"version":"build-2784847793"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Volatile anesthetics have been described as a rescue therapy for patients with refractory status asthmaticus (SA), and the use of isoflurane for this indication has been reported since the 1980s. Much of the literature reports good outcomes when inhaled isoflurane is used as a rescue therapy for patients for refractory SA. Venovenous (VV) extracorporeal membrane oxygenation (ECMO) is a mode of mechanical circulatory support that is usually employed as a potentially lifesaving intervention in patients who have high risk of mortality, primarily for underlying pulmonary pathology. VV ECMO is usually only considered in cases where patients gas exchange cannot be satisfactorily maintained by conventional therapy and mechanical ventilation strategies. We report the novel use of isoflurane delivered systemically as treatment for severe refractory SA in a patient on VV ECMO. A 51-year-old male with a history of asthma was transferred from another institution for management of severe SA. He was intubated at the referring hospital after failing non-invasive ventilation. Initial arterial blood gas (ABG) showed pH 7.21, partial pressure of carbon dioxide (PCO<jats:sub>2<\/jats:sub>) &amp;gt;95 mmHg, and partial pressure of oxygen (PaO<jats:sub>2<\/jats:sub>) 60 mmHg. VV ECMO was initiated on hospital day (HD) 1 due to refractory respiratory acidosis. After ECMO initiation, acid-base status improved, however, severe bronchospasm persisted and intrinsic positive end expiratory pressure (PEEP) was measured at 18 cm H<jats:sub>2<\/jats:sub>O. Systemic paralysis was employed, respiratory rate (RR) was reduced to 4 breaths per minute. This degree of bronchospasm did not allow for ECMO weaning. On HD 5, the patient received systemic isoflurane <jats:italic>via<\/jats:italic> the ECMO circuit for 20 h. The following morning, intrinsic PEEP was 4 cm H<jats:sub>2<\/jats:sub>O, and wheezing improved. He was decannulated from VV ECMO on HD 10 and extubated on HD 17. Inhaled isoflurane therapy in patients on VV ECMO for refractory SA has shown good results, but requires delivery of the medication <jats:italic>via<\/jats:italic> anesthesia ventilators. Our case highlights an effective alternative, systemic delivery of anesthetic <jats:italic>via<\/jats:italic> the ECMO circuit, as it is often difficult and dangerous to transport these patients to the operating room (OR) or have an intensive care unit (ICU) room adjusted to accommodate an anesthesia ventilator.<\/jats:p>","DOI":"10.3389\/fmed.2022.1051468","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T07:17:50Z","timestamp":1667891870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Case report: Isoflurane therapy in a case of status asthmaticus requiring extracorporeal membrane oxygenation"],"prefix":"10.3389","volume":"9","author":[{"given":"Brendan","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Bartock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Damuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0749-0704(05)70324-9","article-title":"Status asthmaticus","volume":"13","author":"Cohen","year":"1997","journal-title":"Crit Care Clin."},{"key":"B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/cc1451","article-title":"Clinical review: severe asthma","volume":"6","author":"Papiris","year":"2002","journal-title":"Crit Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1378\/chest.120.5.1616","article-title":"Clinical course and outcome of patients admitted to an ICU for status asthmaticus","volume":"120","author":"Afessa","year":"2001","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1378\/chest.120.5.1439","article-title":"Intensive care management of status asthmaticus","volume":"120","author":"Shapiro","year":"2001","journal-title":"CHEST J."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD002308","DOI":"10.1002\/14651858.CD002308.pub2","article-title":"Early use of inhaled corticosteroids in the emergency department treatment of acute asthma","volume":"12","author":"Edmonds","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.prrv.2016.07.001","article-title":"Intravenous magnesium sulfate for treating children with acute asthma in the emergency department","volume":"20","author":"Griffiths","year":"2016","journal-title":"Paediatr Respir Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1081-1206(10)61444-5","article-title":"Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations","volume":"93","author":"Pendergraft","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1378\/chest.14-1733","article-title":"Mechanical ventilation for severe asthma","volume":"147","author":"Leatherman","year":"2015","journal-title":"Chest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1378\/chest.110.3.767","article-title":"Noninvasive positive pressure ventilation in status asthmaticus","volume":"110","author":"Meduri","year":"1996"},{"key":"B11","author":"Yartsev","year":"2015","journal-title":"Ventilation strategies for Status Asthmaticus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/23247096211065618","article-title":"Severe ARDS secondary to Legionella pneumonia requiring VV ECMO in the setting of newly diagnosed hairy cell leukemia","volume":"10","author":"Gorman","year":"2022","journal-title":"J Investig Med High Impact Case Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/MAT.0b013e3181901ea5","article-title":"Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus","volume":"55","author":"Mikkelsen","year":"2009","journal-title":"ASAIO J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0267659116670481","article-title":"Extracorporeal membrane oxygenation support for life-threatening acute severe status asthmaticus","volume":"32","author":"Di Lascio","year":"2017","journal-title":"Perfusion."},{"key":"B15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0021-8707(37)90143-6","article-title":"The interruption of the asthmatic crisis by tribromethanol (avertin)","volume":"8","author":"Fuchs","year":"1937","journal-title":"J Allergy."},{"key":"B16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-8707(39)90472-7","article-title":"The relief of severe intractable bronchial asthma with cyclopropane anesthesia","volume":"10","author":"Meyer","year":"1939","journal-title":"J Allergy."},{"key":"B17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1097\/00003246-198609000-00017","article-title":"Prolonged isoflurane anesthesia in status asthmaticus","volume":"14","author":"Bierman","year":"1986","journal-title":"Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1378\/chest.97.3.698","article-title":"Isoflurane therapy for status asthmaticus in children and adults","volume":"97","author":"Johnston","year":"1990","journal-title":"Chest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e231507","DOI":"10.1136\/bcr-2019-231507","article-title":"Volatile anesthetic for treatment of respiratory failure from status asthmaticus requiring extracorporeal membrane oxygenation","volume":"13","author":"LaGrew","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00000542-198202000-00005","article-title":"Mechanism of action of inhalational anesthesia on airways","volume":"56","author":"Hirshman","year":"1982","journal-title":"Anesthesiology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/00000542-199006000-00017","article-title":"Direct and neurally mediated effects of halothane on pulmonary resistance in vivo","volume":"72","author":"Warner","year":"1990","journal-title":"Anesthesiology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0310","DOI":"10.1097\/CCE.0000000000000310","article-title":"Volatile Sedation for Acute Respiratory Distress Syndrome patients on venovenous extracorporeal membrane oxygenation and ultraprotective ventilation","volume":"3","author":"Grasselli","year":"2021","journal-title":"Crit Care Explor"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/00031348211047489","article-title":"Treatment of acute severe asthma exacerbation with extracorporeal membrane oxygenation and inhaled volatile anesthestic","author":"Raff","year":"2021","journal-title":"Am Surg"},{"key":"B24","first-page":"9","article-title":"Correction of hypoxia and hypercapnia in COPD patients: effects on cerebrovascular flow","volume":"52","author":"Cannizzaro","year":"1997","journal-title":"Monaldi Arch Chest Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1886-8","article-title":"Extracorporeal memebrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry","author":"Yeo","year":"2017","journal-title":"Crit Care"},{"key":"B26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MAT.0000000000000466","article-title":"The effects of propofol and isoflurane sedation on the outcomes of surgical patients receiving extracorporeal membrane oxygenation","volume":"63","author":"Verkoyen","year":"2017","journal-title":"ASAIO J."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1051468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T07:17:55Z","timestamp":1667891875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1051468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":26,"alternative-id":["10.3389\/fmed.2022.1051468"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1051468","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"article-number":"1051468"}}